CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 4 Open-market sale Chief Executive Officer sold 2,788 shares at $9.25 ($25,789)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 33,000 shares at $1.62 ($53,460)
- 4 Open-market buy Director bought 12,900 shares at $1.89 ($24,381)
- 4 Open-market sale Director sold 500,000 shares at $9.33 ($4,666,000)
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 8-K Event Shareholder vote results
- 10-Q/A Report 10-Q/A
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 19 of 41 · 808 filings